Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Calvo

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Haematologica|April 28, 2010
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behaviorEva Giné, Antoni Martinez, Neus Villamor, et al.
Nature Communications|November 13, 2024
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trialJuan Jose Rodriguez-Sevilla, Vera Adema, Kelly S Chien, et al.
Cancers|July 13, 2024
Chromogenic <i>LMO2</i> mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOSNatalia Papaleo, Andrea Molina-Alvarez, Ricard Onieva, et al.
Virchows Archiv : an International Journal of Pathology|October 22, 2024
Combined immunohistochemical profile CD10/LMO2/MYC is a useful tool to screen MYC rearrangements in aggressive large B-cell lymphomasNatalia Papaleo, Andrea Molina-Alvarez, Gustavo Tapia, et al.
Leukemia|October 23, 2022
Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemiaNieves Garcia-Gisbert, Leonor Arenillas, David Roman-Bravo, et al.
Leukemia|February 22, 2018
Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progressionCarlos Fernández de Larrea, Ignacio Isola, Arturo Pereira, et al.
Blood Advances|June 16, 2022
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuumXavier Calvo, David Roman-Bravo, Nieves Garcia-Gisbert, et al.
International Journal of Laboratory Hematology|February 22, 2021
Reduced expansion of CD94/NKG2C<sup>+</sup> NK cells in chronic lymphocytic leukemia and CLL-like monoclonal B-cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or NKG2C deletionsAnna Puiggros, Gonzalo Blanco, Aura Muntasell, et al.
Cytometry. Part B, Clinical Cytometry|November 30, 2022
Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemiaRebeca Jurado, Maria Huguet, Blanca Xicoy, et al.
Oncoimmunology|June 7, 2018
Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLLGonzalo Blanco, Anna Vardi, Anna Puiggros, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Haematologica|April 28, 2010
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behaviorEva Giné, Antoni Martinez, Neus Villamor, et al.
Nature Communications|November 13, 2024
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trialJuan Jose Rodriguez-Sevilla, Vera Adema, Kelly S Chien, et al.
Cancers|July 13, 2024
Chromogenic <i>LMO2</i> mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOSNatalia Papaleo, Andrea Molina-Alvarez, Ricard Onieva, et al.
Virchows Archiv : an International Journal of Pathology|October 22, 2024
Combined immunohistochemical profile CD10/LMO2/MYC is a useful tool to screen MYC rearrangements in aggressive large B-cell lymphomasNatalia Papaleo, Andrea Molina-Alvarez, Gustavo Tapia, et al.
Leukemia|October 23, 2022
Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemiaNieves Garcia-Gisbert, Leonor Arenillas, David Roman-Bravo, et al.
Leukemia|February 22, 2018
Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progressionCarlos Fernández de Larrea, Ignacio Isola, Arturo Pereira, et al.
Blood Advances|June 16, 2022
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuumXavier Calvo, David Roman-Bravo, Nieves Garcia-Gisbert, et al.
International Journal of Laboratory Hematology|February 22, 2021
Reduced expansion of CD94/NKG2C<sup>+</sup> NK cells in chronic lymphocytic leukemia and CLL-like monoclonal B-cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or NKG2C deletionsAnna Puiggros, Gonzalo Blanco, Aura Muntasell, et al.
Cytometry. Part B, Clinical Cytometry|November 30, 2022
Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemiaRebeca Jurado, Maria Huguet, Blanca Xicoy, et al.
Oncoimmunology|June 7, 2018
Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLLGonzalo Blanco, Anna Vardi, Anna Puiggros, et al.
Pageof 6